On Tuesday, 25 October, AmCham EU hosted its annual healthcare plenary on ‘Advancing Healthcare Resilience as a response to the COVID-19 pandemic’ featuring a keynote address from Céline Gauer, Head of the Recovery and Resilience Task Force, European Commission. Gauer highlighted the need for reforms and investments both in primary care as well as on a structural level. She also emphasised that the private and public sectors need to work together to ensure sustainability in healthcare, and to promote development in cancer research.
Advancing healthcare resilience after COVID-19
On Tuesday, 25 October, AmCham EU hosted its annual healthcare plenary on ‘Advancing Healthcare Resilience as a response to the COVID-19 pandemic’ featuring a keynote address from Céline Gauer, Head of the Recovery and Resilience Task Force, European Commission. Gauer highlighted the need for reforms and investments both in primary care as well as on a structural level. She also emphasised that the private and public sectors need to work together to ensure sustainability in healthcare, and to promote development in cancer research.
A panel focusing on the question of healthcare policy after COVID also took place. Panellists highlighted that, following the pandemic, the EU has taken concrete steps to create more resilient healthcare system, including in the form of the Recovery and Resilience Faculty. The discussion was moderated by Felix Uedelhoven (GE-Healthcare), Vice-Chair, Healthcare Committee, AmCham EU and featured the following guest speakers:
Frederico Guanais, PhD, Deputy Head, Health Division, Directorate for Employment, Labour and Social Affairs, Organisation for Economic Co-operation and Development (OECD)
Tomislav Sokol MEP (EPP, HR)
For further background, please read our paper on the Digital Healthcare and our latest Transatlantic Economy Report.
Related items
:focal())
News
27 Oct 2025
Advancing EU health policy through competitiveness and innovation
On Monday, 27 October, AmCham EU met with Lorena Boix-Alonso, Deputy Director-General, Directorate-General for Health and Food Safety, European Commission, for an exchange on the role of health policy in strengthening the EU’s competitiveness. The discussion focused on how to foster innovation while ensuring patient safety, as well as ways to streamline the legislative framework to improve efficiency and uphold high standards of care. AmCham EU highlighted the importance of evidence-based, future-proof regulation that supports a resilient health system and drives innovation. Continued dialogue is essential to advancing shared goals for Europe’s health agenda.
:focal())
News
9 Oct 2025
Advancing European healthcare in Strasbourg
From Tuesday, 7 to Wednesday, 8 October, AmCham EU travelled to the European Parliament in Strasbourg, France to engage with MEPs on the future of EU health policy. In meetings with over a dozen policymakers, members underscored the importance of a competitive, innovation-driven life sciences sector that ensures timely patient access to medicines and technologies. The discussions also covered the General Pharmaceutical Legislation, the Medical Devices Regulation, the Critical Medicines Act and the upcoming Biotech Act. The delegation called for evidence-based, proportionate policies that promote regulatory coherence and support Europe’s global leadership in health innovation.
News
4 May 2025
How the Critical Medicines Act will strengthen Europe’s life sciences sector
On Wednesday, 30 April, Thibaut L'Ortye, Senior Director of Public Affairs, AmCham EU, joined a panel discussion on the Critical Medicines Act (CMA). Hosted by the European Policy Centre, Mr L'Ortye underlined the need for open and resilient supply chains to ensure continued access to medicines. He also highlighted the CMA’s potential to strengthen Europe's competitiveness and improve patient access. Avoiding protectionist measures and aligning the CMA with the EU’s wider simplification efforts is essential to attract investment into the Single Market. The discussion highlighted the importance of public-private collaboration to build a more competitive life sciences sector in the EU.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.